×

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

  • US 10,709,738 B2
  • Filed: 02/05/2020
  • Issued: 07/14/2020
  • Est. Priority Date: 02/21/2018
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence of SEQ ID NO:

  • 47,wherein said cancer is selected from colorectal cancer (CRC), gallbladder cancer (GBC), head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC), ovarian cancer (OC), and renal cell carcinoma (RCC).

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×